Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Gastroenterología y Hepatología (English Edition) ; 45(9):697-705, 2022.
Artículo en Inglés | EuropePMC | ID: covidwho-2124875

RESUMEN

Background COVID-19 pandemic increased medical services demand aside from interrupting daily clinical practice for other diseases such as inflammatory bowel disease (IBD). Here we present the results of a survey to gain the perception of IBD specialists in their patient-management using telemedicine in their daily practice. Methods This was an observational survey study among physicians focused on IBD (gastroenterologist, surgeons, and pediatricians) members of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU), the Spanish Association of Gastroenterology (AEG), and the Spanish Association of Coloproctology (AECP), regarding changes of management of IBD patients. Results We received a total of 269 responses to the survey (from May to June 2020). Before the pandemic, nearly all the respondents reported performing very frequently their visits face-to-face (n = 251, 93.3%) while, during the pandemic, the telephone visits were the most frequent visits performed (n = 138, 51.3%). Regarding communication difficulties, 157 (58.4%) respondents reported the impossibility of performing a proper examination as the most relevant issue. Also, 114 (42.4%) respondents considered remote visits more time-consuming than face-to-face visits. Most gastroenterologists (n = 188, 83.2%) considered patients with active perianal disease in special need of face-to-face consultation and more than half of the surgeons (n = 35, 50.7%) reported having performed an immediate postoperative follow-up remotely. Conclusions Most IBD units have implemented remote visits during the pandemic, but most professionals found them more time-consuming and unsuitable for some disease profiles. Therefore, there is a need for the development of better telemedicine systems that can meet professionals’ and patients’ requirements.

2.
Gastroenterología y Hepatología (English Edition) ; 2022.
Artículo en Inglés | EuropePMC | ID: covidwho-1824052

RESUMEN

The COVID-19 pandemic has meant a qualitative change in the way patients are treated in outpatient clinics. The need to take measures of social isolation as prevention for contagion by the new coronavirus has forced the use of telematic and telephone consultations in most medical and surgical units. The specialty of digestive medicine, due to the characteristics of its patients and frequent support in complementary techniques for diagnosis, is especially suitable for the use of non-contact consultations. In this document a series of recommendations are proposed that can serve as a guide for the establishment or improvement of non-face-to-face digestive medicine consultations.

4.
Gastroenterología y Hepatología (English Edition) ; 45(2):123-133, 2022.
Artículo en Inglés | EuropePMC | ID: covidwho-1695379

RESUMEN

Background Patients with inflammatory bowel disease (IBD) are vulnerable to some psychological disorders. Here we describe the psychological impact of a COVID-19 pandemic lockdown in patients with IBD. Methods This multicenter prospective cohort study included 145 patients recently diagnosed with IBD. Data on clinical and demographic characteristics, anxiety and depression scales, and IBD activity were collected in two telephone surveys, during and after the first COVID-19 lockdown in Spain. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. Results During lockdown, 33.1% and 24.1% scored high on the anxiety and depression scales, respectively. Independent factors related to anxiety (all values ORs;95% CIs) during lockdown were female sex (2;1.2–5.4) and IBD activity (4.3;1.8–10.4). Factors related to depression were comorbidity (3.3;1.1–9.8), IBD activity (6;1.9–18.1), use of biologics (2.9;1.1–7.6), and living alone or with one person (3.1;1.2–8.2). After lockdown, anxiety and depression symptoms showed significant improvement, with 24.8% and 15.2% having high scores for anxiety and depression, respectively. Factors related to post-lockdown anxiety were female sex (2.5;1.01–6.3), Crohn's disease (3.3;1.3–8.5), and active IBD (4.1;1.2–13.7). Factors associated with depression were previous history of mood and/or anxiety disorders (6.3;1.6–24.9), active IBD (7.5;2.1–26.8), and steroid use (6.4;1.4–29). Conclusions Lockdown during the COVID-19 pandemic had a significant psychological impact in patients with IBD. Disease activity was related to the presence of anxiety and depression symptoms during and after lockdown.

5.
Gastroenterol Hepatol ; 44(8): 587-598, 2021 Oct.
Artículo en Inglés, Español | MEDLINE | ID: covidwho-1626213

RESUMEN

Patients with certain immune-mediated inflammatory diseases, such as rheumatoid arthritis (RA) and inflammatory bowel disease (IBD), have an increased risk of severe infectious diseases than the general population, which are mainly associated with the immunosuppressive treatments that they receive. These treatments act on the immune system through different mechanisms, causing different degrees of immunosuppression and a variable risk depending on whether the pathogen is a virus, bacteria or fungus. This article reviews the most relevant literature on the subject, which was selected and discussed by a panel of experts. The aim of this article is to review the risk of infections in patients with IBD and RA, and the potential preventive measures.


Asunto(s)
Artritis Reumatoide/terapia , Infecciones Bacterianas/prevención & control , Terapia Biológica/efectos adversos , Inmunosupresores/efectos adversos , Enfermedades Inflamatorias del Intestino/terapia , Inhibidores de las Cinasas Janus/efectos adversos , Virosis/prevención & control , Artritis Reumatoide/inmunología , COVID-19/etiología , Hepatitis A/prevención & control , Hepatitis B/prevención & control , Herpes Zóster/prevención & control , Humanos , Enfermedades Inflamatorias del Intestino/inmunología , Gripe Humana/prevención & control , Infecciones Neumocócicas/prevención & control , Factores de Riesgo , Tuberculosis Pulmonar/prevención & control , Cobertura de Vacunación , Vacunas de Productos Inactivados/administración & dosificación
6.
Gastroenterol Hepatol ; 45(9): 697-705, 2022 Nov.
Artículo en Inglés, Español | MEDLINE | ID: covidwho-1450111

RESUMEN

BACKGROUND: COVID-19 pandemic increased medical services demand aside from interrupting daily clinical practice for other diseases such as inflammatory bowel disease (IBD). Here we present the results of a survey to gain the perception of IBD specialists in their patient-management using telemedicine in their daily practice. METHODS: This was an observational survey study among physicians focused on IBD (gastroenterologist, surgeons, and pediatricians) members of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU), the Spanish Association of Gastroenterology (AEG), and the Spanish Association of Coloproctology (AECP), regarding changes of management of IBD patients. RESULTS: We received a total of 269 responses to the survey (from May to June 2020). Before the pandemic, nearly all the respondents reported performing very frequently their visits face-to-face (n=251, 93.3%) while, during the pandemic, the telephone visits were the most frequent visits performed (n=138, 51.3%). Regarding communication difficulties, 157 (58.4%) respondents reported the impossibility of performing a proper examination as the most relevant issue. Also, 114 (42.4%) respondents considered remote visits more time-consuming than face-to-face visits. Most gastroenterologists (n=188, 83.2%) considered patients with active perianal disease in special need of face-to-face consultation and more than half of the surgeons (n=35, 50.7%) reported having performed an immediate postoperative follow-up remotely. CONCLUSIONS: Most IBD units have implemented remote visits during the pandemic, but most professionals found them more time-consuming and unsuitable for some disease profiles. Therefore, there is a need for the development of better telemedicine systems that can meet professionals' and patients' requirements.


Asunto(s)
COVID-19 , Enfermedades Inflamatorias del Intestino , Telemedicina , Humanos , Pandemias/prevención & control , España/epidemiología , Enfermedades Inflamatorias del Intestino/terapia , Enfermedades Inflamatorias del Intestino/epidemiología , Enfermedad Crónica
7.
Gastroenterol Hepatol ; 45(4): 299-303, 2022 Apr.
Artículo en Inglés, Español | MEDLINE | ID: covidwho-1275326

RESUMEN

The COVID-19 pandemic has meant a qualitative change in the way patients are treated in outpatient clinics. The need to take measures of social isolation as prevention for contagion by the new coronavirus has forced the use of telematic and telephone consultations in most medical and surgical units. The specialty of digestive medicine, due to the characteristics of its patients and frequent support in complementary techniques for diagnosis, is especially suitable for the use of non-contact consultations. In this document a series of recommendations are proposed that can serve as a guide for the establishment or improvement of non-face-to-face digestive medicine consultations.


Asunto(s)
COVID-19 , Telemedicina , Humanos , Pandemias/prevención & control , Derivación y Consulta , Telemedicina/métodos
8.
Gastroenterol Hepatol ; 45(2): 123-133, 2022 Feb.
Artículo en Inglés, Español | MEDLINE | ID: covidwho-1240361

RESUMEN

BACKGROUND: Patients with inflammatory bowel disease (IBD) are vulnerable to some psychological disorders. Here we describe the psychological impact of a COVID-19 pandemic lockdown in patients with IBD. METHODS: This multicenter prospective cohort study included 145 patients recently diagnosed with IBD. Data on clinical and demographic characteristics, anxiety and depression scales, and IBD activity were collected in two telephone surveys, during and after the first COVID-19 lockdown in Spain. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. RESULTS: During lockdown, 33.1% and 24.1% scored high on the anxiety and depression scales, respectively. Independent factors related to anxiety (all values ORs; 95% CIs) during lockdown were female sex (2; 1.2-5.4) and IBD activity (4.3; 1.8-10.4). Factors related to depression were comorbidity (3.3; 1.1-9.8), IBD activity (6; 1.9-18.1), use of biologics (2.9; 1.1-7.6), and living alone or with one person (3.1; 1.2-8.2). After lockdown, anxiety and depression symptoms showed significant improvement, with 24.8% and 15.2% having high scores for anxiety and depression, respectively. Factors related to post-lockdown anxiety were female sex (2.5; 1.01-6.3), Crohn's disease (3.3; 1.3-8.5), and active IBD (4.1; 1.2-13.7). Factors associated with depression were previous history of mood and/or anxiety disorders (6.3; 1.6-24.9), active IBD (7.5; 2.1-26.8), and steroid use (6.4; 1.4-29). CONCLUSIONS: Lockdown during the COVID-19 pandemic had a significant psychological impact in patients with IBD. Disease activity was related to the presence of anxiety and depression symptoms during and after lockdown.


Asunto(s)
COVID-19/psicología , Control de Enfermedades Transmisibles , Enfermedades Inflamatorias del Intestino/psicología , Adulto , Ansiedad , COVID-19/epidemiología , COVID-19/prevención & control , Depresión , Femenino , Humanos , Enfermedades Inflamatorias del Intestino/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Estudios Prospectivos , España
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA